Xenon Pharmaceuticals Inc (XENE)
41.58
+1.78
(+4.47%)
USD |
NASDAQ |
Nov 22, 13:40
Xenon Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2022 | -28.14K% |
| June 30, 2022 | -5.81K% |
| March 31, 2022 | -224.4% |
| December 31, 2021 | -684.1% |
| September 30, 2021 | -190.1% |
| June 30, 2021 | -996.8% |
| March 31, 2021 | -361.7% |
| December 31, 2020 | -239.3% |
| September 30, 2020 | -135.1% |
| June 30, 2020 | -1.31% |
| March 31, 2020 | -105.7% |
| December 31, 2019 | -341.7% |
| September 30, 2019 | -253.5% |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 |
| Date | Value |
|---|---|
| December 31, 2017 | -50.41K% |
| September 30, 2017 | -2.93K% |
| June 30, 2017 | -49.20K% |
| March 31, 2017 | -46.98K% |
| December 31, 2016 | -1.60K% |
| September 30, 2016 | -1.87K% |
| June 30, 2016 | -1.46K% |
| March 31, 2016 | -542.9% |
| December 31, 2015 | -122.0% |
| September 30, 2015 | -89.12% |
| June 30, 2015 | 28.87% |
| March 31, 2015 | -228.3% |
| December 31, 2014 | 25.09% |
| September 30, 2014 | 69.67% |
| June 30, 2014 | 23.22% |
| March 31, 2014 | 27.45% |
| December 31, 2013 | 45.03% |
| September 30, 2013 | 59.12% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-28.14K%
Minimum
Sep 2022
-1.31%
Maximum
Jun 2020
-3.10K%
Average
-290.5%
Median
Profit Margin (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 21.17% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -2.12K% |
| ESSA Pharma Inc | -- |
| ImmunoPrecise Antibodies Ltd | -75.98% |